Thyroid and Cholesterol: Why an Underactive Thyroid Can Make LDL Rise
Your LDL has gone up even though you haven't changed anything? Then it's worth looking at a small organ in your neck. Thyroid hormones help control how many LDL receptors your liver keeps ready.
A high LDL deserves attention. And it deserves the question of where it comes from. Sometimes part of the answer lies not on your plate, but in your neck.
You come home from your checkup and open the lab report. Next to LDL there is an arrow pointing up. Last year the value was still unremarkable.
You eat the way you always do. You move the way you always do, maybe even a little more than before. And still the number points in a direction you don't like.
I bet you know the thought that comes next. Did I do something wrong? Too much cheese, too little exercise, too much stress? On top of that comes a quiet guilt that is hard to shake off. And a question you can't find an answer to: why now, of all times?
May I offer you a different perspective? Your LDL does not only depend on what is on your plate. It also depends on what your liver does with cholesterol. And your liver listens to a hormone from a small organ in your neck: your thyroid.
Thyroid hormone helps control how many docking sites for LDL your liver keeps ready. When hormone is lacking, fewer of these docking sites are available. LDL then stays in the blood longer, and the level can rise. The link between the thyroid and cholesterol has been known for many decades.
To be clear: this article is not a text against statins. When indicated, statins are well studied and a cornerstone of cardiovascular prevention. If you take a statin, this text changes nothing about that. You discuss any change with your doctor.
This is about a step before that: the question of whether there is a cause behind your LDL that can be checked. And the question of how this cause relates to statins, to muscle symptoms and to the value Lp(a).
Three questions for you
- Have you been more tired in recent months than before, even though your sleep has stayed the same?
- Do you feel cold more quickly than the people around you, or has your skin become drier?
- Has your LDL gone up even though hardly anything has changed about your eating and exercise?
If you nod at one or more of these questions, that is not a diagnosis. These signs have many possible causes. But they are a good starting point for a conversation with your doctor.
LDL is also a question of pickup
Imagine a highway that suddenly has many more delivery vans on it. The obvious explanation: more of them are setting off. But there is a second one. Maybe just as many set off as always, but at the destination the loading docks have become scarce. Then the vans back up on the road.
That is exactly how you can picture your LDL. The lab value shows how much LDL is traveling in your blood right now. It says nothing about why there is so much.
The delivery vans and their distribution center
LDL particles are the delivery vans of your metabolism. They bring cholesterol to the cells that need it. Cholesterol is not an enemy, but building material. Your cells need it for their membranes, your adrenal glands and sex glands for hormones, your liver for bile acids.
The liver is both the distribution center and the pickup station. It sends fat transporters called VLDL into the blood. Along the way, these transporters release fat and become smaller, until they turn into LDL. In the end, it is mainly the liver that takes LDL back out of the blood.
For this pickup, the liver cell needs loading docks. In medical terms, they are called LDL receptors. They sit on the surface of the liver cell, grab an LDL particle and pull it inside. There the cholesterol is put to use, and the receptor often returns to the surface.
Every LDL particle carries a protein called apolipoprotein B, or ApoB for short. This is how the receptor recognizes the delivery van, just as a loading dock recognizes a license plate. Because every particle carries exactly one ApoB, this value shows fairly accurately how many delivery vans are on the road.
How the liver cell decides how many docks to set up
How many docks a liver cell sets up is no coincidence. It constantly measures how much cholesterol it contains itself. If its supply is low, it builds more receptors to get fresh supplies from the blood. If its supply is high, it scales back construction.
This sensor sits in a membrane inside the cell. When cholesterol runs low, a site manager called SREBP-2 moves into the cell nucleus. There it switches on the gene for the LDL receptor. Remember this site manager. It is about to play a leading role.
So your LDL value always has two sides: how much LDL is made, and how quickly it is picked up again. A high value can mean that more is being produced. But it can also mean that pickup is stalling.
In 1981, a research group led by Thompson measured directly in the body how quickly LDL is broken down via its receptor. In two people with homozygous familial hypercholesterolemia this pathway was missing, and in one person with an underactive thyroid it was clearly reduced and got going again under levothyroxine.
For you, this means: an underactive thyroid can slow down the same pickup pathway that a severe genetic defect blocks entirely, only this brake can be released.
Thompson GR et al. Proc Natl Acad Sci U S A. 1981;78(4):2591-2595. DOI: 10.1073/pnas.78.4.2591 [Case, n=3]Homozygous familial hypercholesterolemia is a rare inherited disorder. In it, both copies of the gene for the LDL receptor are altered. Three people are not a large study. But they show the pathway this article is about: pickup via the LDL receptor.
Whether and when levothyroxine is an option for you is always for your doctor to clarify. You'll find a detailed look at this further down.
A high LDL does not automatically mean: eaten too much. It can also mean: picked up too little.
This thought takes away the guilt, but not the curiosity. It invites you to ask the right question before you judge yourself.
What can you do with this knowledge? If your LDL has recently gone up, make a note for your next appointment of since when and under what circumstances. A trend over several years says more than a single value.
And now you know why an LDL value always has two sides: production and pickup.
How the thyroid controls the liver's loading docks
Maybe you have heard that the thyroid controls metabolism. That sounds abstract. What is an organ in your neck supposed to have to do with a number in your lipid profile? More than you might think. And the path there is surprisingly concrete.
From storage hormone to light switch
Your thyroid mainly makes T4. This is a kind of storage form that travels with the blood to all organs. Only in the tissues do enzymes turn it into T3, the active form. You can read how this conversion works in the article From T4 to T3.
T3 is the pacesetter. It travels into the cell and all the way into the nucleus. There it binds to a receptor that sits directly on the genetic material. This works like a light switch: when T3 is bound, certain genes are switched on or off.
In the liver cell, these genes include the genes for cholesterol balance. That brings us back to the loading docks. Thyroid hormone intervenes in their life cycle in at least two places: during construction and during demolition.
First control point: the site manager
Remember SREBP-2, the site manager? It switches on the gene for the LDL receptor. Thyroid hormone appears to help determine how much of this site manager there is. Less hormone then means fewer site managers, and fewer site managers means fewer docks.
In 2003, Shin and Osborne studied in mice and in cell lines which switch thyroid hormone uses to control cholesterol. The hormone regulates the gene for SREBP-2, and more active SREBP-2 in mice with an underactive thyroid activated the LDL receptor and brought the elevated cholesterol levels back down.
For you, this means: these are animal and cell data, but they provide a wiring diagram that fits well with observations in humans.
Shin DJ, Osborne TF. J Biol Chem. 2003;278(36):34114-34118. DOI: 10.1074/jbc.M305417200 [In vivo, mouse model and cell lines]Second control point: the demolition crew
Loading docks are not only built, they are also torn down. A protein called PCSK9 takes care of that. It attaches itself to the LDL receptor. Normally the receptor returns to the surface after unloading. With PCSK9 in tow, it is broken down inside the cell instead.
So PCSK9 is the demolition crew. The more active it is, the fewer docks remain. By the way, a modern group of cholesterol-lowering drugs targets exactly this crew: the PCSK9 inhibitors.
In 2014, a research group led by Bonde at the Karolinska Institute studied people with an overactive thyroid and healthy people taking a thyroid hormone analogue. In both cases, PCSK9, LDL cholesterol, apolipoprotein B and Lp(a) fell, while the body's own cholesterol production stayed stable.
For you, this means: thyroid hormone might influence LDL mainly through pickup, less through production.
Bonde Y et al. J Lipid Res. 2014;55(11):2408-2415. DOI: 10.1194/jlr.M051664 [Pathophysiology, human study, n=34]Strictly speaking, this study looked at people with a lot of hormone, not a little. In it, 20 people with an overactive thyroid were measured before and after their treatment. In addition, 14 healthy people received the active substance eprotirome, a thyroid hormone analogue, for 14 days. It seems plausible that, conversely, more PCSK9 circulates in the blood with an underactive thyroid. But that was not measured here.
A second finding is also interesting. Under thyroid hormone, the liver made more bile acids, through which the body gets rid of cholesterol. According to the data, however, this route was not decisive for the fall in LDL.
This creates a picture with two dials. Thyroid hormone might promote the construction of docks and slow down their demolition. When hormone is lacking, both dials turn in the same unfavorable direction: fewer new docks, more demolition. The delivery vans back up in the blood.
In a 2018 review, Sinha, Singh and Yen compiled how thyroid hormones directly control fat metabolism in the liver. They describe effects on the formation of new fat, fat burning, cholesterol synthesis and the return transport of cholesterol, and they link an underactive thyroid with elevated triglycerides, elevated cholesterol and fatty liver.
For you, this means: for the liver, the thyroid is not a supporting actor but a pacesetter.
Sinha RA, Singh BK, Yen PM. Nat Rev Endocrinol. 2018;14(5):259-269. DOI: 10.1038/nrendo.2018.10 [Mechanism review]This fits into a bigger picture. Thyroid hormone helps determine how quickly your cells turn over energy. With an underactive thyroid, many things run more slowly, including the processing of fats in the liver. LDL is just the part you see right away in the lab.
Thyroid hormone is not a cholesterol-lowering drug. It is a pacesetter that tells the liver at what pace to work.
When this rhythm is missing, a rising LDL is not a character flaw and not a diet mistake. It can be a signal that a hormone is lacking.
What does this mean in practice? If you have older lab reports, put your thyroid values next to your lipid values. Take both trends to your next appointment. Sometimes two series of numbers tell more together than each one alone.
And now you know why a hormone from your neck can have a say in a number in your lipid profile.
Even a mild underactive thyroid can show up in your lipid profile
Your TSH is just below the upper limit of the reference range. There is no asterisk on the report. Everything within range, you are told. And yet for months you have felt as if you were driving with the handbrake on.
Maybe you wonder whether a value in the normal range can have anything to do with your LDL at all. The answer is surprising: it can.
The gas pedal sits in your head
To understand this, it helps to take a look at the brain. There, a control center called the hypothalamus constantly measures how much thyroid hormone is circulating in the blood. If there is too little, it sends a signal to the pituitary gland. The pituitary then releases TSH.
TSH is the gas pedal. It drives the thyroid to make more hormone. When the thyroid gets tired, the brain presses harder on the pedal. So a high TSH means: the gas pedal is pushed far down so that the hormone level is still sufficient.
That is exactly what subclinical hypothyroidism is. TSH is elevated, while free T4 is still within the reference range. The thyroid manages its workload, but only with a lot of gas. Which values count here and how to read them is explained in the article Thyroid blood tests: which ones count.
The symptoms of an underactive thyroid also have to do with your nervous system. Thyroid hormone helps determine how much energy and heat your cells produce, including your nerve cells. When it is lacking, this can feel like an engine running at reduced power: fatigue, feeling cold, slower thinking.
In Norway, researchers led by Asvold examined 30,656 adults in the HUNT Study whose TSH was within the reference range. The higher the TSH within this range, the higher total cholesterol, LDL, non-HDL and triglycerides were, and the lower HDL was.
For you, this means: in metabolism, the line between normal and abnormal is more of a gradient than a wall.
Asvold BO et al. Eur J Endocrinol. 2007;156(2):181-186. DOI: 10.1530/eje.1.02333 [Real-World, cross-sectional n=30,656]The association appeared in women of all age groups and in men over 50. It was stronger in people with excess weight. One limitation is important: a cross-sectional study measures everything at a single point in time. It shows an association, but no proof that one thing causes the other.
In 2002, a research group led by Caraccio compared a total of 49 people with subclinical hypothyroidism with 33 healthy people and then tested levothyroxine against placebo. Total cholesterol, LDL and apolipoprotein B were higher and rose with TSH, and under levothyroxine, total cholesterol and LDL fell more clearly the higher they had been before.
For you, this means: even a mild underactive thyroid can show up in your lipid profile, and the change was larger when baseline values were higher.
Caraccio N et al. J Clin Endocrinol Metab. 2002;87(4):1533-1538. DOI: 10.1210/jcem.87.4.8378 [RCT, n=49]At the Amsterdam AMC, Diekman and colleagues examined 1,509 people who had been referred to a specialist clinic because of elevated blood lipids. Of them, 4.2 percent, or 64 people, had an underactive thyroid, and in 39 of these it was newly discovered, including 28 subclinical cases.
For you, this means: among people with high blood lipids, an undetected underactive thyroid is not a rarity, which is why the authors recommended a TSH test for everyone.
Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Arch Intern Med. 1995;155(14):1490-1495. DOI: 10.1001/archinte.1995.00430140052004 [Real-World, cohort n=1,509]In this group, newly discovered overt hypothyroidism was about twice as common as in the general population. That is no reason to worry. It is a reason to think of the thyroid when blood lipids are high.
When the immune system slowly throttles the thyroid
Where does an underactive thyroid come from in the first place? In regions with an adequate iodine supply, the most common cause is Hashimoto's thyroiditis. In this condition, the immune system turns against the body's own thyroid tissue.
At the cellular level, it looks like this: immune cells migrate into the thyroid. Inflammatory messengers disrupt hormone production, and little by little, tissue that can make hormone is lost. Antibodies against the enzyme TPO make this process visible in the blood. You can read more about this in the article Hashimoto's and the immune system.
This process often creeps along over years. TSH rises slowly, and the gas pedal is pressed down a little further, bit by bit. And LDL can follow this course without anything having changed in your everyday life.
Within the reference range means: 95 percent of healthy people fall there. It does not mean that the value is meaningless for you.
A TSH in the upper reference range is not, on its own, a reason for treatment. But it is a reason to keep an eye on the trend.
What you can take from this: at your next appointment, don't just ask whether your TSH is normal. Ask exactly where it lies and how it has changed over the years. And ask whether antibodies against TPO have ever been measured.
And now you know why even a value that is still normal can tell a story when you look at it over the years.
What this means for your heart
Maybe during the conversation about your LDL a word came up that stuck with you: heart attack. It rides home with you. It speaks up in the evening, when things get quiet.
This worry is understandable. It is even biology. Fear switches your nervous system to high alert, and in this state clear thinking is hard. That is why it is worth translating the worry into questions. The first one is: what does LDL do to your blood vessels?
When delivery vans park in the vessel wall
Your blood vessels are lined on the inside with a wafer-thin layer of cells, the endothelium. It is like the road surface of your highway. The more delivery vans are on the road, the more of them get through this surface into the vessel wall.
Some of them get stuck there. Their contents are altered by aggressive oxygen compounds, and experts call this oxidized LDL. To your immune system, this altered LDL looks like a foreign body.
Now scavenger cells move in, the macrophages. They take up the altered LDL, more and more of it. Imagine a garbage collection crew that gorges itself. Stuffed with fat, the scavenger cells become so-called foam cells.
These foam cells send out inflammatory signals. The signals attract more immune cells, and the hotspot grows. Over the years, this can turn into a deposit in the vessel wall, the plaque. That is why atherosclerosis is not only a fat problem, but also an inflammatory process.
In 2019, the European Society of Cardiology and the European Atherosclerosis Society presented a joint guideline on managing blood lipids. In it, LDL is considered a causal factor in atherosclerosis, and lowering LDL is a central means of reducing cardiovascular risk.
For you, this means: an elevated LDL is not a cosmetic flaw in your lab report, it deserves a serious assessment, no matter where it comes from.
Mach F et al. Eur Heart J. 2020;41(1):111-188. DOI: 10.1093/eurheartj/ehz455 [Review, guideline]For your blood vessels, it makes no difference at first where the LDL comes from. LDL that rises because of an underactive thyroid consists of the same delivery vans as any other LDL. That is why the question about your thyroid is also a question about your heart.
What large datasets show about TSH and the heart
Are there also direct data on the thyroid and the heart? Yes. One of the largest analyses on this dates from 2010.
In 2010, an international consortium led by Rodondi analyzed the individual data of 55,287 people from 11 cohorts, 3,450 of them with subclinical hypothyroidism. With a TSH of 10 to 19.9 mU/L, the risk of coronary events such as a heart attack was about 1.9 times higher, while at 4.5 to 6.9 mU/L it was not increased.
For you, this means: the risk seems to grow with the level of TSH, and all-cause mortality was not increased in this analysis.
Rodondi N et al. JAMA. 2010;304(12):1365-1374. DOI: 10.1001/jama.2010.1361 [Meta-analysis, individual participant data, k=11, n=55,287]In between, with a TSH of 7.0 to 9.9 mU/L, the risk of coronary events was slightly higher, but not with statistical certainty. Mortality from coronary heart disease showed a similar stepwise pattern. It was already higher from a TSH of 7, and somewhat higher still from 10.
An association in cohort data is not yet proof of cause and effect. Part of it could run through LDL, part through other routes, such as vascular function. You will find a study on this further down. Whether treatment lowers this risk is a question these data do not answer.
What you can take from this: with a slightly elevated TSH, panic is out of place. With a clearly elevated TSH, attention is warranted. In both cases, the assessment belongs in medical hands.
I know this pattern very well. Someone comes to me with a lab report showing that their LDL has risen noticeably within one to two years. Nothing has changed about their eating, nor about their exercise.
Only when I ask do other things come up. A tiredness that does not go away even after a vacation. Cold hands, dry skin, a few extra kilos for no apparent reason. Each detail sounds harmless on its own.
Together, they form a picture. But the puzzle pieces often sit in different chapters of medicine. The LDL is filed under blood lipids, the tiredness somewhere under general wellbeing. Only when both sides lie next to each other does the pattern become visible.
The lesson: two findings in two chapters can share a common story.
Checking your thyroid does not delay protecting your heart. It makes that protection more precise.
If your heart risk is high, your doctor will decide whether both should run in parallel: the thyroid workup and lipid therapy. One does not rule out the other.
What does this mean for your next appointment? Ask about your overall cardiovascular risk, not just your LDL. That includes blood pressure, blood sugar, smoking and your family's heart history. Add your thyroid values, and a fuller picture emerges.
And now you know why the question about your thyroid is part of protecting your heart, not a distraction from it.
What levothyroxine can and cannot change about LDL
Maybe there is already a pack of levothyroxine in your bathroom cabinet. Or the question is in the air whether you need one. And somewhere in the back of your mind lives a hope: once your thyroid is well adjusted, your LDL is bound to come down too.
This hope is not unfounded. But it deserves honest numbers. Because how much changes depends heavily on how pronounced the underactive thyroid is and how high your LDL was before.
Nothing in this section is a reason to start, increase or stop thyroid medication on your own. Too much thyroid hormone can promote heart rhythm disorders and bone loss. Your doctor always decides on starting it and on the dose.
What the studies measured
Levothyroxine, also known as L-thyroxine, is the active substance most often used for an underactive thyroid. It corresponds to the body's own T4. The question of what it changes about cholesterol has been well studied. The answers are encouraging, but they are smaller than many people hope.
In 2000, Danese and colleagues pooled the data from 13 studies with 247 people with mild thyroid failure who received levothyroxine. On average, LDL fell by 0.26 mmol/L, or about 10 mg/dL, and more so with higher baseline values, while HDL and triglycerides stayed unchanged.
For you, this means: the effect is measurable but moderate, and it tends to be larger the higher your cholesterol was before.
Danese MD et al. J Clin Endocrinol Metab. 2000;85(9):2993-3001. DOI: 10.1210/jcem.85.9.6841 [Meta-analysis, k=13, n=247]Total cholesterol fell by 0.20 mmol/L on average. One detail from this analysis is especially revealing. In people whose known underactive thyroid had previously not been adequately treated, total cholesterol fell by 0.44 mmol/L. In previously untreated mild thyroid failure, it was only 0.14 mmol/L.
If you already take levothyroxine and your LDL is rising, it is therefore worth asking whether your thyroid treatment is still well adjusted. Your doctor will answer this question based on your values.
In Basel, a research group led by Meier treated 66 women with subclinical hypothyroidism and a mean TSH of 11.7 mU/L with levothyroxine or placebo for 48 weeks, double-blind. Under levothyroxine, LDL fell by 0.33 mmol/L, or 8.2 percent, more clearly with a TSH above 12 mU/L, and symptoms decreased.
For you, this means: with a clearly elevated TSH, medically guided treatment can moderately lower LDL, and some people also feel better with it.
Meier C et al. J Clin Endocrinol Metab. 2001;86(10):4860-4866. DOI: 10.1210/jcem.86.10.7973 [RCT, n=66]The reduction was also clearer when baseline LDL was high. Apolipoprotein B fell as well, in other words the number of delivery vans. HDL, triglycerides and Lp(a), on the other hand, stayed unchanged. Of the 66 women, 63 stayed in the study to the end.
The authors calculated that such an LDL reduction could lower cardiovascular mortality by 9 to 31 percent. That is an estimate, not a measurement. Heart attacks were not counted in this study.
In Gateshead, England, a research group led by Razvi treated 100 people with subclinical hypothyroidism and a mean TSH of 6.6 mU/L for 12 weeks each with levothyroxine and with placebo, in alternating order. Under levothyroxine, LDL fell from 142.9 to 131.3 mg/dL, vascular function improved, and fatigue eased.
For you, this means: even with only a moderately elevated TSH, this study found measurable changes in cholesterol, in the blood vessels and in wellbeing.
Razvi S et al. J Clin Endocrinol Metab. 2007;92(5):1715-1723. DOI: 10.1210/jc.2006-1869 [RCT, Crossover, n=100]Of the 100 participants, 81 were women, and the average age was just under 54. Vascular function was measured with an ultrasound test. It shows how well an artery widens when more blood flows through it. This value rose from 4.2 to 5.9 percent. The waist-to-hip ratio also became slightly smaller, from 0.83 to 0.81.
This is the study I referred to in the section about your heart. It suggests that thyroid hormone might be linked to the blood vessels not only through LDL, but also through the vessel wall itself.
Why the evidence is not entirely consistent
Not every study comes to the same result. In the Amsterdam lipid clinic mentioned earlier, cholesterol fell clearly after treatment only with a TSH of 10 mU/L or more. However, only 21 people were evaluated there.
So whether treatment makes sense for you does not depend on LDL alone. What counts is the level of TSH, the antibodies, your symptoms, your age and any other conditions you have. Your doctor weighs this up together with you.
A look at the research: the hormone pathway alongside a statin
One study shows especially vividly how powerful the route via the liver's thyroid hormone receptors can be. It works with an active substance that you will not be prescribed. Still, it tells a lot about the mechanism.
In 2010, Ladenson and colleagues gave people who were already taking a statin either the thyroid hormone analogue eprotirome or a placebo in addition, for twelve weeks. LDL fell by 7 percent on placebo and by 22 to 32 percent on eprotirome, depending on the dose, and ApoB, triglycerides and Lp(a) also decreased.
For you, this means: the hormone pathway to the liver can still add an effect even on top of a statin, although eprotirome is not a medication you can get at the pharmacy.
Ladenson PW et al. N Engl J Med. 2010;362(10):906-916. DOI: 10.1056/NEJMoa0905633 [RCT, 12 weeks]Eprotirome was developed to act on the liver as selectively as possible. During the twelve weeks, there were no recognizable side effects on the heart or bones. TSH and T3 stayed unchanged, while T4 in the blood fell. For you, this study is not a treatment option, but evidence of how closely thyroid hormone and LDL pickup are linked.
The studies at a glance
| Study | Who | What happened to LDL |
|---|---|---|
| Danese 2000 | 13 studies, 247 people | fell by 0.26 mmol/L |
| Meier 2001 | 66 women, mean TSH 11.7 mU/L | fell by 0.33 mmol/L (8.2 percent) |
| Razvi 2007 | 100 people, mean TSH 6.6 mU/L | fell from 142.9 to 131.3 mg/dL |
| Diekman 1995 | 21 people evaluated | clear reduction only from a TSH of 10 mU/L |
| Caraccio 2002 | 49 people with subclinical hypothyroidism | fell, more clearly the higher the baseline value |
Levothyroxine is not a cholesterol medication. It makes up for a hormone deficiency. Where there is no deficiency, extra thyroid hormone is not a route to a lower LDL, but a risk for heart and bones.
The question is not: does levothyroxine lower my cholesterol? The question is: is my body lacking thyroid hormone?
If so, LDL can change as the deficiency is made up. If not, the cause lies elsewhere, and then other routes move to the forefront, including lipid therapy.
What you can do in concrete terms: if you already take levothyroxine and your LDL has risen, bring up at your next appointment whether your thyroid values are still in the target range. Your doctor adjusts the dose, not you alone.
And now you know why levothyroxine can influence LDL when the thyroid is underactive, but is not a route to lower cholesterol when the thyroid is healthy.
Statins and your thyroid: not an either-or
Maybe you already take a statin. Or there is a prescription on the table, and you are hesitating. Maybe you have heard about muscle pain and wonder whether it will happen to you.
And maybe a new question comes up now: if my thyroid plays a role, do I even need a statin? This question is fair. The answer is not an either-or.
Two routes to the same loading docks
In the liver cell, statins slow down an enzyme the cell needs for its own cholesterol production. The cell notices: my supply is dropping. So it sends out the site manager SREBP-2, and more loading docks are built. More docks take more LDL out of the blood.
So statins and thyroid hormone meet at the same place: the liver's loading docks. The statin makes the cell need more docks. According to the mechanistic data, thyroid hormone helps the cell actually build and keep those docks.
That is why the two are not opponents. Let me say it clearly once more at this point: when indicated, statins are a cornerstone of cardiovascular prevention and are mostly well tolerated.
When your muscles speak up
Still, some people develop muscle symptoms on a statin. Aching, heaviness, sore muscles without any workout. That is unpleasant, and it is unsettling. This is where the thyroid comes into play a second time.
In 2015, an expert panel of the European Atherosclerosis Society led by Stroes compiled what is known about muscle symptoms on statins. Severe muscle damage with a strongly elevated CK, a muscle enzyme in the blood, is rare, and among the risk factors for symptoms the panel also lists an untreated or inadequately treated underactive thyroid.
For you, this means: if muscle symptoms appear on a statin, your thyroid is one of the things your doctor can check.
Stroes ES et al. Eur Heart J. 2015;36(17):1012-1022. DOI: 10.1093/eurheartj/ehv043 [Review, consensus]According to this consensus, 7 to 29 percent of people on statins report muscle symptoms in registries and observational studies. Not every one of these symptoms comes from the statin. That, too, is a reason to look closely and to rule out other causes first.
For people with muscle symptoms, the panel describes a clear path. The aim is to find the highest statin dose that is well tolerated. If needed, other cholesterol-lowering drugs are added so that LDL targets remain within reach. A structured workup, usually with at least three different statins, is meant to show whether the symptoms are clinically significant. The panel calls statins the cornerstone of cardiovascular prevention.
A research group led by Robison in the Intermountain network in the USA compared 2,686 people with statin intolerance with 8,103 people who tolerated their statin. Among those with intolerance, 30.2 percent had a history of hypothyroidism, compared with 21.5 percent in the comparison group, and the odds ratio was 1.49.
For you, this means: if a statin gives you trouble, an underactive thyroid can be a piece of the puzzle worth checking.
Robison CD et al. J Clin Lipidol. 2014;8(4):401-407. DOI: 10.1016/j.jacl.2014.05.005 [Real-World, case-control n=10,789]Put simply, an odds ratio of 1.49 means: the odds of finding a history of hypothyroidism were almost one and a half times as high in the group with intolerance. In women, it was 1.60, in men 1.29.
A case-control study shows an association, not proof. It also cannot always clarify how well the thyroid was adjusted at the time the statin was taken.
Why might an underactive thyroid make muscles more sensitive? Thyroid hormone helps determine how much energy the power plants of your muscle cells produce, the mitochondria. An underactive thyroid can itself cause muscle pain and an elevated CK. According to preclinical studies, statins can also dampen energy production in the mitochondria. When both come together, the strains could add up. This is mechanistically plausible, but not proven in detail.
Never stop a statin on your own, and do not change the dose without talking to your doctor first. If you have severe muscle weakness, pronounced muscle pain or dark, cola-colored urine, talk to a doctor the same day.
Thyroid or statin is the wrong question. The better one is: check the thyroid, then decide together.
Sometimes making up a hormone deficiency is enough. Sometimes both are needed. And sometimes a well-adjusted thyroid can make the path to a statin easier.
What you can do in concrete terms: if you take a statin and have muscle symptoms, note when and where they occur. Bring them up promptly and ask whether your TSH has been measured. Until that conversation, take your statin as agreed with your doctor. If the warning signs from the box above appear, get in touch the same day.
And now you know why statins and the thyroid are not opponents, but act at the same place.
Lp(a): the value the thyroid barely explains
Maybe your lab report shows a value you never paid attention to before. Lp(a), with an asterisk next to it. You search for it online and come across words like heart attack and heredity. And now you wonder whether this value is also connected to your thyroid.
The short answer is: barely. The longer answer is still worth it. Because Lp(a) helps shape your heart risk, even when your LDL looks good.
A delivery van with a trailer hitch
Remember the delivery vans that carry cholesterol through your blood? Lp(a), pronounced lipoprotein little a, is at its core one of these LDL particles. But attached to its ApoB is an extra protein, apolipoprotein(a). Imagine it as a delivery van with a trailer hitch.
This hitch often tows risky cargo: oxidized phospholipids, that is, fat building blocks altered by oxygen. The scavenger cells in the vessel wall, your immune system's garbage collection crew, can recognize them as a danger signal. They then release inflammatory messengers. In this way, Lp(a) can promote inflammation beneath the road surface of your blood vessels and drive atherosclerosis forward.
The blueprint for the trailer hitch is largely written in your genes. So how high your Lp(a) is depends to a large extent on inheritance. According to current knowledge, diet and exercise change this value only a little.
In 2022, an expert panel of the European Atherosclerosis Society led by Kronenberg summarized what is known about Lp(a). It describes Lp(a) as a causal risk factor for cardiovascular disease and aortic valve stenosis, even with very low LDL, and recommends at least one measurement in adulthood.
For you, this means: Lp(a) is a separate building block of your heart risk that a single blood test can make visible.
Kronenberg F et al. Eur Heart J. 2022;43(39):3925-3946. DOI: 10.1093/eurheartj/ehac361 [Review, consensus]Aortic valve stenosis is a narrowing of the valve between the heart and the main artery. The panel describes the link with cardiovascular disease as continuous: the higher the Lp(a), the higher the risk. According to this consensus, however, the data so far do not support the idea that Lp(a) also promotes blood clots in the veins, for example in the legs.
What the thyroid does and does not change about Lp(a)
Now it gets exciting. Lp(a) keeps turning up in the thyroid studies, and a surprisingly clear pattern emerges.
In the study from Pisa led by Caraccio, an elevated Lp(a) was more common in subclinical hypothyroidism than in the comparison group. But this finding was linked to diabetes or coronary heart disease in the family. Under levothyroxine, Lp(a) did not change.
The authors concluded that an abnormal Lp(a) here reflects a genetic influence rather than a lack of thyroid hormone. In the Basel study, too, Lp(a) stayed unchanged under levothyroxine.
Things look very different with a lot of hormone. In the Stockholm study led by Bonde, Lp(a) was lower during an overactive thyroid than after its treatment. It also fell under eprotirome, both there and in the study by Ladenson.
So thyroid hormone seems to move Lp(a) only when a great deal of it reaches the liver. According to these data, a mild deficiency barely changes the value. And an overactive thyroid is not a way to lower Lp(a). Too much thyroid hormone can throw the heart out of rhythm and weaken the bones.
What matters with a high Lp(a)
At first, a high Lp(a) feels like fate. At the time of this 2022 consensus, there was not yet an approved medication developed specifically to lower Lp(a). Such substances were being tested in studies at the time. It is best to discuss the current state of things with your doctor.
The panel therefore recommends tackling the other risk factors early and consistently, such as LDL, blood pressure, blood sugar and smoking. How strictly this is done depends on your overall heart risk and on the level of Lp(a).
With a very high Lp(a) and heart disease that progresses despite the best treatment, lipoprotein apheresis may be an option. This is a kind of blood washing that filters Lp(a) and LDL out of the blood.
Your family can also play a role. With familial hypercholesterolemia, meaning an inherited, very high LDL, it can make sense to have relatives tested as well. The same applies to a high Lp(a) or to early heart disease in your family or in yourself.
An elevated Lp(a) is not a verdict. It is a piece of information.
The trailer hitch can hardly be removed through lifestyle. But together with your doctor, you can turn all the other dials that protect your heart. And the sooner you know about it, the more time you have for that.
What you can do in concrete terms: look through your old lab reports to see whether Lp(a) has ever been measured. If not, ask about it at your next appointment. If there is a value, discuss what it means for your overall heart risk.
And now you know why the thyroid can play a role in LDL, but barely in Lp(a).
Supported by large RCTs / meta-analyses: In subclinical hypothyroidism, levothyroxine can lower LDL moderately on average, by about 0.26 to 0.33 mmol/L (Danese, Meier, Razvi). The randomized trials on this, however, are small. In pooled data from 55,287 people, the risk of coronary events was increased mainly from a TSH of 10 mU/L (Rodondi). That LDL contributes causally to atherosclerosis is supported by large studies, as is the benefit of statins when indicated (Mach). The classification of Lp(a) as a separate risk factor also rests on a broad body of data (Kronenberg).
Mechanistically plausible, human studies still thin: That T3 controls the liver's loading docks via the site manager SREBP-2 comes mainly from animal and cell data (Shin and Osborne). That less hormone lets the docks be torn down faster via more PCSK9 is derived from a small human study with a lot of hormone (Bonde). The link between an underactive thyroid and muscle symptoms on statins is also plausible, but not proven in detail. That oxidized fat building blocks on Lp(a) promote inflammation in the vessel wall is mechanistically well founded, but only partly studied in humans.
Clinical tradition without a strong study base: Measuring free T4 and thyroid antibodies as well when TSH is abnormal is common practice. What additional benefit these values offer specifically for assessing cholesterol has hardly been studied.
In my clinical practice I observe that the question about the thyroid can easily get lost when LDL rises anew. Cholesterol and hormones are often discussed at different appointments. That is my experience, not a study.
A lab value is a question, not a matter of guilt. When you know the cause, you decide more freely.
Three levers for your next doctor's appointment
Remember the arrow pointing up on your lab report? And the quiet guilt that came with it? Maybe you now see this arrow with different eyes.
It is not automatically a report card on your behavior. It is a clue that can be followed up. Sometimes it leads to the thyroid, sometimes to your genes, sometimes to lifestyle, and often to several things at once.
In the end, this is what it's about: not a number, but making decisions about your heart out of clarity instead of fear. Clarity is freedom. And freedom often begins with a single good question.
Your three levers
- Have your thyroid checked first. If your LDL has risen recently or unusually, ask for your TSH to be measured, and if the value is abnormal, your free T4 as well. Ideally, this happens before lipid therapy is planned. If your heart risk is high, your doctor will decide whether both are tackled in parallel.
- Bring your history along. Bring your LDL values from recent years, your thyroid values, your medication list and your family's heart history. A trend tells more than a single value.
- Have your Lp(a) measured once. Ask whether your Lp(a) has already been measured. The European Atherosclerosis Society recommends at least one measurement in adulthood, because the value is largely genetically determined.
If you already take levothyroxine or a statin, don't change anything on your own. Take your questions with you to the appointment. There, you and your doctor decide together what is right for you.
And now you know why your next doctor's appointment can begin with a simple question: how is my thyroid doing?
If you'd like to do more than read and get started right away: below this article you'll find the option to book an appointment.
Frequently asked questions about thyroid and cholesterol
Can an underactive thyroid raise cholesterol?
Yes, it can. Thyroid hormone helps control how many LDL receptors the liver makes. When hormone is lacking, the liver clears LDL from the blood more slowly, and the level can rise. That is why it is worth having your thyroid checked when your cholesterol is high.
Why does LDL rise with an underactive thyroid?
Mainly because pickup slows down. In the liver cell, thyroid hormone can switch on genes needed to build LDL receptors. It also appears to slow down the protein PCSK9, which breaks these receptors down. With less hormone, LDL particles can stay in the blood longer. Some of these mechanisms come from animal and cell studies.
Can subclinical hypothyroidism also raise LDL?
That is possible. In subclinical hypothyroidism, TSH is elevated while free T4 is still within the reference range. A study from Pisa found higher levels of total cholesterol, LDL and apolipoprotein B in this group, rising along with TSH. The difference is usually moderate and often clearer when TSH is higher.
Is LDL linked to the thyroid even within the TSH reference range?
The Norwegian HUNT Study examined 30,656 adults whose TSH was within the reference range. The higher the TSH, the higher total cholesterol, LDL and triglycerides were. This is a statistical association from a cross-sectional study, not proof of cause and effect. A TSH in the upper reference range is not, on its own, a reason for treatment. But it is a value whose trend you deserve to know.
Should the thyroid be checked when cholesterol is high?
Yes, that makes sense, especially if your LDL has risen recently or unusually. In an Amsterdam lipid clinic, 4.2 percent of referred people had an underactive thyroid, and in many it had gone undetected until then. The authors therefore recommended a TSH test for everyone. Ask your doctor about it, ideally before lipid therapy is planned. If your heart risk is high, your doctor will decide whether both should run in parallel.
How much can levothyroxine lower LDL?
In subclinical hypothyroidism, rather moderately. A meta-analysis of 13 studies found an average reduction of 0.26 mmol/L. In the Basel study it was 0.33 mmol/L, or 8.2 percent. The reduction was larger with higher baseline LDL and higher TSH. Whether treatment is an option for you is for your doctor to decide.
At what TSH level is the effect clearest?
In two studies, the LDL reduction was clearest with clearly elevated TSH. In the Basel study, LDL fell more with a TSH above 12 mU/L. In a small analysis from Amsterdam, a clear reduction appeared only from a TSH of 10 mU/L. A study from Gateshead, however, also found a reduction at a mean TSH of 6.6 mU/L. So the evidence is not entirely consistent.
Is thyroid hormone a remedy for high cholesterol?
No, not if your thyroid is healthy. Levothyroxine makes up for a hormone deficiency. Where there is no deficiency, extra hormone is not a way to lower cholesterol. It can then strain the heart and bones. That is why thyroid medication always belongs in medical hands.
Do I still need a statin if my thyroid is being treated?
That depends on your overall heart risk, not just on your thyroid. In some people, LDL may fall enough once the underactive thyroid is treated, while for others lipid therapy remains sensible. When indicated, statins are well studied and a cornerstone of cardiovascular prevention. You make the decision together with your doctor.
Can an underactive thyroid make muscle symptoms on statins more likely?
That is possible. An expert panel of the European Atherosclerosis Society lists untreated or inadequately treated hypothyroidism among the risk factors. In a large case-control study, people with statin intolerance more often had a history of hypothyroidism. Never stop a statin on your own if you have symptoms, and talk to your doctor promptly instead.
Does an underactive thyroid increase heart risk?
In subclinical hypothyroidism, this seems to depend on the TSH level. One analysis pooled data from 55,287 people. With a TSH of 10 to 19.9 mU/L, the risk of coronary events was about 1.9 times higher. At 4.5 to 6.9 mU/L, it was not increased. All-cause mortality was not increased in this analysis. Your doctor will assess your personal risk based on all your values.
What does Lp(a) have to do with the thyroid?
Little, as far as studies show so far. Lp(a) is largely genetically determined. In two studies on subclinical hypothyroidism, it remained unchanged under levothyroxine. It was lower during an overactive thyroid and under a thyroid hormone analogue. Still, an overactive thyroid is not a way to lower Lp(a), because too much thyroid hormone can strain the heart and bones.
Should I have my Lp(a) measured once?
A consensus paper of the European Atherosclerosis Society recommends at least one measurement in adulthood. It considers an elevated level a causal risk factor for cardiovascular disease and for narrowing of the aortic valve. With familial hypercholesterolemia or early heart disease in the family, it can make sense to have relatives tested too. Ask your doctor about it.
I have Hashimoto's: do I need to watch my cholesterol?
It makes sense to know your lipid profile. Over the years, Hashimoto's can progress to an underactive thyroid, and an underactive thyroid can raise LDL. If your LDL rises, it is worth asking whether your thyroid levels are still well adjusted. Always discuss changes to your medication with your doctor.
How this article connects to the others
Your LDL is only one of the places where the thyroid can show itself. These articles pick up the threads.
Thyroid and cholesterol
How the thyroid can influence LDL.
You're reading thisThyroid blood tests: which ones count
Making sense of TSH, fT4, fT3 and antibodies.
Symptoms despite levothyroxine
When your values are good and the symptoms remain.
Hashimoto's and the immune system
Why the immune system can attack the thyroid.
From T4 to T3
How the conversion works in the liver and tissues.
Functional hypothyroidism
When your metabolism runs slower than your values suggest.
Normal values, still symptoms
What may lie behind this common experience.
The thyroid's building blocks
Selenium, zinc, iron and vitamin D at a glance.
Scientific sources
- Thompson GR et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci U S A. 1981;78(4):2591-2595. DOI: 10.1073/pnas.78.4.2591 [Case, n=3]
- Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J Biol Chem. 2003;278(36):34114-34118. DOI: 10.1074/jbc.M305417200 [In vivo, mouse model and cell lines]
- Bonde Y et al. Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans. J Lipid Res. 2014;55(11):2408-2415. DOI: 10.1194/jlr.M051664 [Pathophysiology, human study, n=34]
- Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018;14(5):259-269. DOI: 10.1038/nrendo.2018.10 [Mechanism review]
- Asvold BO et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181-186. DOI: 10.1530/eje.1.02333 [Real-World, cross-sectional n=30,656]
- Caraccio N et al. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87(4):1533-1538. DOI: 10.1210/jcem.87.4.8378 [RCT, n=49]
- Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med. 1995;155(14):1490-1495. DOI: 10.1001/archinte.1995.00430140052004 [Real-World, cohort n=1,509]
- Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. DOI: 10.1093/eurheartj/ehz455 [Review, guideline]
- Rodondi N et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374. DOI: 10.1001/jama.2010.1361 [Meta-analysis, individual participant data, k=11, n=55,287]
- Danese MD et al. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85(9):2993-3001. DOI: 10.1210/jcem.85.9.6841 [Meta-analysis, k=13, n=247]
- Meier C et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860-4866. DOI: 10.1210/jcem.86.10.7973 [RCT, n=66]
- Razvi S et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715-1723. DOI: 10.1210/jc.2006-1869 [RCT, Crossover, n=100]
- Ladenson PW et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med. 2010;362(10):906-916. DOI: 10.1056/NEJMoa0905633 [RCT, 12 weeks]
- Stroes ES et al. Statin-associated muscle symptoms: impact on statin therapy. European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36(17):1012-1022. DOI: 10.1093/eurheartj/ehv043 [Review, consensus]
- Robison CD et al. Hypothyroidism as a risk factor for statin intolerance. J Clin Lipidol. 2014;8(4):401-407. DOI: 10.1016/j.jacl.2014.05.005 [Real-World, case-control n=10,789]
- Kronenberg F et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. DOI: 10.1093/eurheartj/ehac361 [Review, consensus]